MAP2K7 and head and neck squamous cell carcinoma: Combining autophagy inhibition using HCQ and MEK inhibition via trametinib enhanced apoptosis in HNSCC cells, suggesting that trametinib-induced autophagy is protective and that there is a synthetic lethality between autophagy and MEK signaling.